Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy

Ying Jing(Nanchang University), Leng Han(Indiana University Health)
Nature Communications
October 2, 2020
10.1038/s41467-020-18742-9
Cited by 206

Related Papers

Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
|Cell Reports|2018|521
Comprehensive molecular characterization of mitochondrial genomes in human cancers
|Nature Genetics|2020|516
The landscape of aging
|Science China Life Sciences|2022|404
Biomarkers of aging
|Science China Life Sciences|2023|362
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
|Nature Communications|2019|297